|
On June 8, 2006, the New England Journal of Medicine published
an article reporting that infants whose mothers had taken an
angiotensin-converting enzyme inhibitor (ACE inhibitors)
drug during the first trimester of pregnancy had an increased
risk of major congenital malformations, compared with infants who
had not undergone first trimester exposure to ACE inhibitor drugs.
Ace inhibitors are prescribed for control of high blood pressure.
Mothers who took these regularly-prescribed blood pressure medications
in their first trimester were more than twice as likely to have children
born with serious heart and brain problems than mothers who did not take
any blood pressure-lowering drugs. Many of these blood pressure medications
have been on the market for 25 years.
Call Gempeler Law Firm if you believe you or a loved one has suffered
congenital malformations from the use of an Ace Inhibitor during pregnancy.
1-866-547-0009
Disclaimer:
Colorado ACE Inhibitor Attorney Disclaimer: Denver and
Breckenridge ACE Inhibitor and/or other legal information
offered herein by Gempeler Trial Lawyers is not formal
legal advice, nor the formation of an attorney client
relationship. Each case is different and the outcome
of your personal injury case will depend on the merits
of your factual situation and applicable law. An Attorney-Client
relationship is not created by visiting this web site.
No Attorney-Client relationship is created until a retainer
agreement is signed. |
